Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANSWER: Human Albumin for Ascites in Cirrhosis
NCT01288794Phase 4Completed
- Sponsor
- Alma Mater Studiorum – Università di Bologna
- Start
- Mar 2011
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albumin (human) in ascites (2 arms), sponsored by Alma Mater Studiorum – Università di Bologna. Primary endpoint: Mortality at 18 months. Started Mar 2011; status: completed.
02
Drugs
albumin (human)
03
Conditions
ascites
Beyond the preview
Go deeper on NCT01288794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288794.